Zynex Inc Book/Share
What is the Book/Share of Zynex Inc?
The Book/Share of Zynex Inc is 0.69
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Zynex Inc
What does Zynex Inc do?
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Companies with book/share similar to Zynex Inc
- Awale Resources has Book/Share of 0.69
- Creative Enterprise has Book/Share of 0.69
- Platform 9 Capital has Book/Share of 0.69
- Monaker Inc has Book/Share of 0.69
- Alumina has Book/Share of 0.69
- Air China has Book/Share of 0.69
- Zynex Inc has Book/Share of 0.69
- China Overseas Property has Book/Share of 0.69
- Subversive Capital Acquisition has Book/Share of 0.69
- Visagar Polytex has Book/Share of 0.69
- Mega Uranium has Book/Share of 0.69
- London City Equities has Book/Share of 0.69
- Optim has Book/Share of 0.69